Original Article/BiliaryEndobiliary radiofrequency ablation for malignant biliary obstruction
References (17)
- et al.
Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction
Gastrointest Endosc
(2011) - et al.
Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents
Gastrointest Endosc
(2002) - et al.
Endoscopic bilateral metal stent placement for malignant hilar stenoses: identification of optimal technique
Gastrointest Endosc
(2000) - et al.
Initial performance profile of a new 6F self-expanding metal stent for palliation of malignant hilar biliary obstruction
Gastrointest Endosc
(2010) - et al.
Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma: a pilot study of a newly designed Y stent
Gastrointest Endosc
(2007) - et al.
Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video)
Gastrointest Endosc
(2009) - et al.
Expandable metal stents for endoscopic bilateral stent-within-stent placement for malignant hilar biliary obstruction
Gastrointest Endosc
(2010) - et al.
Endoscopic 3-branched partial stent-in-stent deployment of metallic stents in high-grade malignant hilar biliary stricture (with videos)
Gastrointest Endosc
(2007)
There are more references available in the full text version of this article.
Cited by (66)
History of the Interventional Pancreaticobiliary Endoscopy
2024, Gastrointestinal Endoscopy Clinics of North AmericaEndobiliary Ablation Improves Survival in Patients With Unresectable Perihilar Cholangiocarcinoma Compared to Stenting Alone
2022, Techniques and Innovations in Gastrointestinal EndoscopyCitation Excerpt :Three meta-analyses comparing PDT (delivered percutaneously and endoscopically) to stenting alone in malignant biliary obstruction showed improved survival,12,26,27 and PDT-associated survival ranged from 66-420 days.14,15,28-33 RFA has been shown to improve stent patency and biliary luminal diameter.16,22-24,34-37 Studies assessing the impact of RFA on survival in cases of malignant biliary obstruction compared to stenting alone showed mixed results, though a recent meta-analysis did show a survival benefit.23
Intraductal Therapies for Cholangiocarcinoma
2022, Techniques and Innovations in Gastrointestinal EndoscopyEndoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma
2019, Gastrointestinal Endoscopy Clinics of North AmericaPercutaneous endobiliary radiofrequency ablation for refractory benign hepaticojejunostomy and biliary strictures
2018, Diagnostic and Interventional Imaging
Copyright © 2013 The Editorial Board of Hepatobiliary & Pancreatic Diseases International. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.